Savara (SVRA) Depreciation & Amortization - Total (2016 - 2018)
Savara (SVRA) reported Depreciation & Amortization - Total of $139000.0 for Q4 2018, up 52.75% year-over-year from $91000.0 in Q4 2017, and up 9.45% on a QoQ basis from $127000.0 in Q3 2018.
Savara (SVRA) has 3 years of Depreciation & Amortization - Total data on file, last reported at $139000.0 in Q4 2018.
- Quarterly Depreciation & Amortization - Total rose 52.75% year-over-year to $139000.0 in Q4 2018, while the trailing twelve-month figure through Sep 2019 was $139000.0 (down 70.92% YoY) and the FY2021 annual result came in at $100000.0, down 66.67% from the prior year.
- Depreciation & Amortization - Total rose to $139000.0 in Q4 2018 per SVRA's latest filing, from $127000.0 in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $153000.0 in Q2 2018 and bottomed at $85000.0 in Q2 2016.
- The 3-year median for Depreciation & Amortization - Total is $91000.0 (2017), against an average of $104545.5.
- The widest annual swing landed in 2017, when Depreciation & Amortization - Total gained 1.11%; it then jumped 68.13% in 2018.
- Tracing SVRA's Depreciation & Amortization - Total over 3 years: stood at $90000.0 in 2016, then advanced by 1.11% to $91000.0 in 2017, then soared by 52.75% to $139000.0 in 2018.
- Per Business Quant, the three latest SVRA Depreciation & Amortization - Total figures stand at $139000.0 (Q4 2018), $127000.0 (Q3 2018), and $153000.0 (Q2 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 139,000.00 |
| Sep 30, 2018 | 127,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Mar 31, 2018 | 107,000.00 |
| Dec 31, 2017 | 91,000.00 |
| Sep 30, 2017 | 91,000.00 |
| Jun 30, 2017 | 91,000.00 |
| Mar 31, 2017 | 90,000.00 |
| Dec 31, 2016 | 90,000.00 |
| Sep 30, 2016 | 86,000.00 |
| Jun 30, 2016 | 85,000.00 |